Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingredia is a global dairy company specializing in the development and manufacture of innovative ingredients for the health, nutrition, and food industries. As a subsidiary of the French cooperative La Prospérité Fermière, the company leverages advanced milk fractionation technologies to produce bioactive proteins and specialized dairy powders. Their flagship products include Lactium, a milk protein hydrolysate for stress management, and various micellar caseins and whey proteins for clinical and sports nutrition. Ingredia operates with a strong focus on sustainability and quality standards, serving customers in the pharmaceutical, nutraceutical, and functional food sectors. The company is recognized for its research into milk-derived bioactives that target specific health concerns such as sleep quality and immune support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingredia Dairy Experts.